Pulmonary Fibrosis_Interstitial Lung Disease

Gene: ASAH1

Red List (low evidence)

ASAH1 (N-acylsphingosine amidohydrolase 1)
EnsemblGeneIds (GRCh38): ENSG00000104763
EnsemblGeneIds (GRCh37): ENSG00000104763
OMIM: 613468, ClinGen, DECIPHER
ASAH1 is in 13 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Red List (low evidence)

Respiratory insufficiency due to muscle weakness in Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950, does not fit with panel scope.
Created: 16 Dec 2025, 11:18 a.m. | Last Modified: 16 Dec 2025, 11:18 a.m.
Panel Version: 0.126

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950; Farber lipogranulomatosis, MIM# 228000

Sue White (Victorian Clinical Genetics Services)

Biallelic variants in the ASAH1 gene are associated with a spectrum of disorders ranging from Farber disease (FD) to spinal muscular atrophy with or without progressive myoclonic epilepsy (SMA‐PME). FD presents most commonly in infants with subcutaneous joint nodules, progressive arthritis and granulomas of the larynx and epiglottis leading to a hoarse cry. SMA‐PME is characterized by childhood onset progressive weakness due to motor neuron disease followed by progressive epilepsy, tremor, and sensorineural hearing loss.
Created: 2 Nov 2020, 4:13 p.m. | Last Modified: 2 Nov 2020, 4:13 p.m.
Panel Version: 0.5257

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Publications

Details

Mode of Inheritance
Unknown
Sources
  • Expert Review Red
  • Victorian Clinical Genetics Services
  • Victorian Clinical Genetics Services
Phenotypes
  • Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950
  • Farber lipogranulomatosis, MIM# 228000
OMIM
613468
ClinGen
ASAH1
DECIPHER
ASAH1
Clinvar variants
Variants in ASAH1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

16 Dec 2025, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ASAH1 were changed from Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950; Farber lipogranulomatosis, MIM# 228000 to Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950; Farber lipogranulomatosis, MIM# 228000

16 Dec 2025, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: asah1 has been classified as Red List (Low Evidence).

16 Dec 2025, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ASAH1 were changed from to Spinal muscular atrophy with progressive myoclonic epilepsy, MIM# 159950; Farber lipogranulomatosis, MIM# 228000

16 Dec 2025, Gel status: 1

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ASAH1 were set to

16 Dec 2025, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: asah1 has been classified as Red List (Low Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ASAH1 was added gene: ASAH1 was added to Pulmonary Fibrosis_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ASAH1 was set to Unknown